Atara Biotherapeutics
Atara Biotherapeutics, Inc. is a leading allogeneic T-cell immunotherapy company pioneering the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune diseases.Leveraging our novel allogeneic EBV T-cell platform, Atara intends to deliver treatments to patients with high unmet medical need. Our platform aims to leverage the unique biology of EBV T cells to channel the power of the immune system and has the potential to treat a wide range of diseases. Atara is applying this one platform to create a robust pipeline with the goal of developing treatments that improve the quality and longevity of patients' lives.
Total raised: $90.5M

Investors 2

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
10.01.2014Series B$52M--
17.12.2013Series B$38.5M-Atara Biot...

Mentions in press and media 6

29.06.2016The biotec...There was a time af­ter the 2...FinancingJohn
10.01.2014 Atara ...Thousand Oaks-based Atara Biot...--socaltech....
10.01.2014Atara Biot...Atara Biotherapeutics, Inc., a...funding
17.12.2013Atara Biot...Atara Biotherapeutics, Inc., a...funding
17.12.2013 Atara ...Thousand Oaks-based biopharmac...--socaltech....
01.11.2012 Atara ...Thousand Oaks-based Amgen and ...--socaltech....